Newsletters

Dec 93 min read

The Vitals: Exactech Lawsuit, Clinical Trial Diversity, & A New Remote Innovation

Catch up on Exactech's lawsuit, a new remote innovation, and the use of virtual patients in medical device clinical trials.

6 views0 comments

Dec 23 min read

The Vitals: Breakthrough Materials, New Coatings, Innovative Surgical Robots, and Jason Scherer Workshop

Catch up on new materials and coatings, innovative medical robots, and CEO Jason Scherer's live workshop on medical device mistakes.

6 views0 comments

Nov 202 min read

The Vitals: FDA Biocompatibility Guide, 3G Shutdown, New Devices, & Vita Visits MEDICA Düsseldorf

Weekly MedTech News Brought To You By Your Friends At VitaTek. FDA Biocompatibility Guide, 3G Shutdown, New Devices, & Vita Visits MEDICA

28 views13 comments

Nov 52 min read

The Vitals: Big FDA News, 23andme DNA Data Drama & Game-Changing AFib Treatment

Weekly MedTech News Brought To You By Your Friends At VitaTek. Catch up on FDA's big news, 23andMe's data drama, and a new AFib Treatment.

231 views66 comments

Oct 172 min read

The Vitals: Human Factors, Supply Shortages, & Regulatory Answers

Weekly MedTech News Brought To You By Your Friends At VitaTek!

59 views1 comment

Apr 26 min read

VitaTek Newsletter 2024 Q1

Welcome to our Q1 2024 newsletter! We're excited to share our latest updates with you, including the expansion of our EO sterilization...

187 views0 comments

Dec 22, 20237 min read

VitaTek Newsletter 2023 Q4

Catch up with us in our Q4 2023 Newsletter! Find updates for our 70k sqft headquarter's buildout plan, OEM medical device timelines, & more!

180 views0 comments

Jul 18, 20235 min read

Q2 2023 Newsletter: Vita Group Medical Device Incubator

Welcome to our 2023 Q2 newsletter! We have news on Brekka and StingRay, project updates, and an important new hire to the company.

130 views0 comments

Mar 28, 20234 min read

Q1 2023 Newsletter: Vita Group Medical Device Incubator

Welcome to our 2023 Q1 Vita Group Medical Device newsletter! We hope this finds you well and that you're excited to dive into the latest...

73 views0 comments